Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.445 +0.025 (+1.76%)
Streaming Delayed Price Updated: 9:53 AM EDT, Sep 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 160,621
Open 1.410
Bid (Size) 1.440 (9,100)
Ask (Size) 1.450 (14,800)
Prev. Close 1.420
Today's Range 1.400 - 1.445
52wk Range 0.5632 - 2.979
Shares Outstanding 210,356,896
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Inovio (INO) Q2 2026 Earnings Call Transcript ↗
INO-3107 advances toward October FDA decision as company extends cash runway through early 2027. 
Via The Motley Fool
Topics Earnings
News headline image
Inovio Pharmaceuticals Q2 Earnings Call Highlights ↗
Inovio Pharmaceuticals (NASDAQ:INO) said the U.S. Food and Drug Administration has completed several key steps in its review of the company’s biologics license application for INO-3107, an... 
Via MarketBeat
Topics Earnings

Performance

YTD
-14.5%
-14.5%
1 Month
+96.2%
+96.2%
3 Month
+31.4%
+31.4%
6 Month
-16.5%
-16.5%
1 Year
-49.7%
-49.7%

More News

Read More
Here are the top movers in Thursday's session. ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗
Via Chartmill
News headline image
Inovio Pharmaceuticals Shareholders Back Board as INO-3107 FDA Review Advances ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
Inovio (INO) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Biotech Stocks Rally on Hantavirus Fears: Is the Surge Overdone? ↗
Via The Motley Fool
Topics Death
Get insights into the top gainers and losers of Friday's after-hours session. ↗
Via Chartmill
News headline image
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO
From Pomerantz LLP
Via GlobeNewswire
News headline image
Inovio Deadline Today: Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
INO CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals Investors of Securities Class Action Deadline on April 7, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Urgently Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Before April 7th
From Bragar Eagel & Squire
Via GlobeNewswire
On Monday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
News headline image
Deadline Soon: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
Here are the top movers in Thursday's session. ↗
Via Chartmill
Top movers analysis in the middle of the day on 2026-04-02: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
What's Behind The Drop In Inovio Pharmaceuticals Stock Today? ↗
Via Benzinga
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
Discover the top movers in Thursday's pre-market session. ↗
Via Chartmill
News headline image
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO
From Pomerantz LLP
Via GlobeNewswire

Frequently Asked Questions

Is Inovio Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Inovio Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Inovio Pharmaceuticals, Inc. - Common Stock trade on?
Inovio Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock is INO on the Nasdaq Stock Market
What is the current price of Inovio Pharmaceuticals, Inc. - Common Stock?
The current price of Inovio Pharmaceuticals, Inc. - Common Stock is 1.445
When was Inovio Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Inovio Pharmaceuticals, Inc. - Common Stock was at 09/09/26 09:53 AM ET
What is the market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock is 303.97M
How many shares of Inovio Pharmaceuticals, Inc. - Common Stock are outstanding?
Inovio Pharmaceuticals, Inc. - Common Stock has 304M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.